KENDRA MECHE: Open Payments
NPI 1326295239 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 52 payments from 17 companies in 2025. Trend: 2023 $905 · 2024 $1,523 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $136 |
| Sumitomo Pharma America, Inc. | 5 | $133 |
| Novo Nordisk Inc | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| Exact Sciences Corporation | 3 | $59 |
| Dexcom, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Amgen Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
Products named: GEMTESA, UBRELVY, Dexcom G6 Transmitter, Auvelity, BREZTRI, Wegovy, Rybelsus, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
